Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (Q44950867)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial |
scientific article |
Statements
1 reference
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (English)
1 reference
Salim Yusuf
1 reference
Janice Pogue
1 reference
Koon Teo
1 reference
Peter Sleight
1 reference
Craig Anderson
1 reference
Farouk Mookadam
1 reference
Barbara Ramos
1 reference
Lutz Hilbrich
1 reference
Helmut Schumacher
1 reference
ONTARGET/TRANSCEND Investigators
1 reference
1 July 2004
1 reference
1 reference
148
1 reference
1
1 reference
52-61
1 reference
Identifiers
1 reference
1 reference